Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...
Researchers evaluated a second-generation nine-lectin microarray that accurately profiles critical glycan epitopes on intact therapeutic monoclonal antibodies without requiring enzymatic glycan ...
CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray assays ...
Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal ...
A prospective pharmacogenetic study of thymidylate synthase (TS) polymorphisms in high risk stage II or stage III colon cancer patients treated with 5-fluorouracil (5-FU) and leucovorin (LV) ...
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, ...
During the continued progression of the coronavirus pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies -- ...
Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Microarray Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global ...
Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Microarray Scanners - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global microarray scanners market was valued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results